News & Updates

Show Multimedia Only

Vaccination drive seeks to prevent pneumococcal disease in vulnerable communities

10 Jan 2023 by

The recent World Pneumonia Day 2022 saw the Malaysian Red Crescent Society (MRCS) partner with Pfizer Malaysia and non-governmental organizations such as BeVital, Community Health Care Clinic, PT Foundation, Ihsan Johor Relief and the National Cancer Society of Malaysia to vaccinate and protect 6,000 children and adults against pneumococcal disease.

Vaccination drive seeks to prevent pneumococcal disease in vulnerable communities

10 Jan 2023

Digital Pathology is a field whose time has come.

10 Jan 2023 by

During the recent Digital Pathology Congress: Malaysia – National Policy on the Development and Use of Digital Pathology Technology, a panel of diverse speakers shared their experiences and insights on the rapidly developing field of digital Anatomic Pathology (AP), one of seven disciplines under the broad category of Laboratory Medicine.

Digital Pathology is a field whose time has come.

10 Jan 2023

$While many are focused on prevention of primary fractures, it is double important to prevent a secondary fracture.$

While many are focused on prevention of primary fractures, it is double important to prevent a secondary fracture.

10 Jan 2023 by

In conjunction with World Osteoporosis Day (WOD), which falls on 20 October, Bone Health Alliance Malaysia (BHAM) urges Malaysians to prioritize bone health management and subsequent osteoporotic fracture prevention.

While many are focused on prevention of primary fractures, it is double important to prevent a secondary fracture.

10 Jan 2023

Corticosteroid poses no excess mortality risk in drug-induced liver injury

09 Jan 2023

Treatment with corticosteroid in patients with drug-induced liver injury (DILI) does not appear to contribute to increased risk of death but rather helps normalize liver enzymes, as shown in a study.

Corticosteroid poses no excess mortality risk in drug-induced liver injury

09 Jan 2023

Caudate, left hepatic lobes involved in liver injury in distal oesophageal carcinoma patients

09 Jan 2023

A recent study has shown the involvement of the caudate and left hepatic lobes in cases of radiation-induced liver injury (RILI) in patients with distal oesophageal carcinoma. Imaging patterns of RILI on fluorodeoxiglucose-positron emission tomography/computed tomography (FDG-PET/CT) also include one or two regions of increased FDG uptake with a nodular, diffuse, or combined appearance.

Caudate, left hepatic lobes involved in liver injury in distal oesophageal carcinoma patients

09 Jan 2023

Valacyclovir after allogeneic HCT reduces CMV infection

09 Jan 2023 by

Viral prophylaxis with valacyclovir 1 g three times daily following allogeneic haematopoietic cell transplantation (HCT) results in a lower incidence of clinically significant cytomegalovirus (CMV) infection as compared with acyclovir, according to a study.

Valacyclovir after allogeneic HCT reduces CMV infection

09 Jan 2023

Veterans with bladder pain syndrome report more food sensitivities

09 Jan 2023

Food sensitivities are significantly more common among veterans with interstitial cystitis/bladder pain syndrome than those without, according to a study.

Veterans with bladder pain syndrome report more food sensitivities

09 Jan 2023

Farm life safeguards children against allergic rhinitis

09 Jan 2023 by

Growing up on a farm appears to confer a reduced risk of developing allergic rhinitis in children, with the protective effect of farm living being set until school age and sustained through early adulthood.

Farm life safeguards children against allergic rhinitis

09 Jan 2023

$Refractory Crohn’s disease responds well to risankizumab$

Refractory Crohn’s disease responds well to risankizumab

09 Jan 2023

In the treatment of patients with luminal Crohn’s disease and multiple prior drug failures, risankizumab induces clinical response in about three out of four patients and steroid-free clinical remission in about half, according to a study.

Refractory Crohn’s disease responds well to risankizumab

09 Jan 2023

Reducing 1L venetoclax to 7 days feasible in elderly AML patients ineligible for intensive chemo

09 Jan 2023 by

In treatment-naïve elderly patients with acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy (IC), reducing venetoclax (VEN) exposure to 7 days concurrently with azacitidine (AZA) (7+7 scheme) led to similar response rates as the recommended protocol of 28 days of VEN plus 7 days of AZA (28+7 scheme), a retrospective study has shown.

Reducing 1L venetoclax to 7 days feasible in elderly AML patients ineligible for intensive chemo

09 Jan 2023

News & Updates

Filter by Specialty:

Specialty:

Vaccination drive seeks to prevent pneumococcal disease in vulnerable communities

Vaccination drive seeks to prevent pneumococcal disease in vulnerable communities

Digital Pathology is a field whose time has come.

Digital Pathology is a field whose time has come.

While many are focused on prevention of primary fractures, it is double important to prevent a secondary fracture.

While many are focused on prevention of primary fractures, it is double important to prevent a secondary fracture.

Corticosteroid poses no excess mortality risk in drug-induced liver injury

Corticosteroid poses no excess mortality risk in drug-induced liver injury

Caudate, left hepatic lobes involved in liver injury in distal oesophageal carcinoma patients

Caudate, left hepatic lobes involved in liver injury in distal oesophageal carcinoma patients

Valacyclovir after allogeneic HCT reduces CMV infection

Valacyclovir after allogeneic HCT reduces CMV infection

Veterans with bladder pain syndrome report more food sensitivities

Veterans with bladder pain syndrome report more food sensitivities

Farm life safeguards children against allergic rhinitis

Farm life safeguards children against allergic rhinitis

Refractory Crohn’s disease responds well to risankizumab

Refractory Crohn’s disease responds well to risankizumab

Reducing 1L venetoclax to 7 days feasible in elderly AML patients ineligible for intensive chemo

Reducing 1L venetoclax to 7 days feasible in elderly AML patients ineligible for intensive chemo